1. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging

   • Haejin In
   • Ethan Ravetch
   • Takeshi Sano

   Special Article 25 September 2017 Pages: 1 - 9

   

2. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis

   • Sara Jamel
   • Sheraz R. Markar
   • George B. Hanna

   Review Article Open access 04 August 2017 Pages: 10 - 18

   

3. Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature

   • Nicole van der Wielen
   • Jennifer Straatman
   • Donald L. van der Peet

   Review Article Open access 20 July 2017 Pages: 19 - 30

   

4. Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma

   • Kazuto Harada
   • Xiaochuan Dong
   • Jaffer A. Ajani

   Original Article 11 August 2017 Pages: 31 - 40

   

5. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer

   • Meng Xie
   • Dafydd Alwyn Dart
   • Jia-Fu Ji

   Original Article Open access 10 May 2017 Pages: 41 - 54

   

6. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast

   • Hiroto Saito
   • Sachio Fushida
   • Tetsuo Ohta

   Original Article Open access 24 May 2017 Pages: 55 - 67

   

7. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A)

   • Takeo Fukagawa
   • Hitoshi Katai
   • on behalf of the Stomach Cancer Study Group of the Japan Clinical Oncology Group

   Original Article 13 February 2017 Pages: 68 - 73

   

8. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy

   • Naruhiko Ikoma
   • Mariela Blum
   • Brian D. Badgwell

   Original Article 22 June 2017 Pages: 74 - 83

   

9. Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)

   • Yuji Miura
   • Yasutaka Sukawa
   • Ichinosuke Hyodo

   Original Article 11 May 2017 Pages: 84 - 95

   

10. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry

    • A. Carmona-Bayonas
    • P. Jiménez-Fonseca
    • AGAMENON study group

    Original Article 09 April 2017 Pages: 96 - 105

    

11. Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer

    • Kohei Shitara
    • Shigenori Kadowaki
    • Kei Muro

    Original Article 30 June 2017 Pages: 106 - 113

    

12. A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607)

    • Noriaki Hasuike
    • Hiroyuki Ono
    • Gastrointestinal Endoscopy Group of Japan Clinical Oncology Group (JCOG-GIESG)

    Original Article 21 February 2017 Pages: 114 - 123

    

13. The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer

    • Keiichi Fujiya
    • Kohei Takizawa
    • Masanori Terashima

    Original Article 08 May 2017 Pages: 124 - 132

    

14. Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis

    • Hye Kyung Jeon
    • Gwang Ha Kim
    • Tae Yong Jeon

    Original Article 10 April 2017 Pages: 133 - 143

    

15. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007)

    • Hitoshi Katai
    • Takashi Ishikawa
    • Registration Committee of the Japanese Gastric Cancer Association

    Original Article 17 April 2017 Pages: 144 - 154

    

16. Long-term outcomes of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG0703)

    • Naoki Hiki
    • Hitoshi Katai
    • On behalf of Stomach Cancer Study Group of Japan Clinical Oncology Group

    Original Article 16 January 2017 Pages: 155 - 161

    

17. Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study

    • Naoki Hiki
    • Michitaka Honda
    • Seigo Kitano

    Original Article 08 September 2017 Pages: 162 - 170

    

18. The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien–Dindo classification in radical gastric cancer surgery

    • Tae-Han Kim
    • Yun-Suhk Suh
    • Han-Kwang Yang

    Original Article 08 June 2017 Pages: 171 - 181